Posted by Michael Wonder on 21 Feb 2017
Agenda for CHMP 20-23 February 2017 meeting
20 February 2017 - The EMA has published a draft agenda for this month's CHMP meeting.
The CHMP is scheduled to give opinion on the following initial applications:
- Emtricitabine with tenofovir disoproxil fumarate
- Sodium zirconium cyclosilicate
- Pemetrexed disodium heptahydrate
- Rituximab
- Edoxaban tosylate
- Rolapitant
- Rituximab
